Key facts: DexCom faces class action lawsuit; stock rises 3.9% amid Fed comments
Lesedauer weniger als 1 min
- A class action lawsuit was filed against DexCom, Inc. on November 21, 2025, alleging false statements about its G6 and G7 glucose monitoring systems from July 26, 2024, to September 17, 2025.1
- DexCom, Inc. (DXCM) saw a 3.9% stock price rise due to positive market sentiment after comments from New York Federal Reserve President John Williams about a potential interest rate cut.2